•Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study
•Swertiamarin promotes barrier function to alleviate ulcerative colitis by inducing autophagy via the PI3K/AKT/mTOR-signaling pathway
•The impact of normalization of histology on disease course in microscopic colitis: a retrospective cohort study
•Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
•Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAID